DanielRKaulMD

Transplant/Immunocompromised States

Professor of Medicine

Dr. Kaul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1500 East Medical Center Dr
3rd Floor Taubman Ctr Recp D
Ann Arbor, MI 48109
Phone+1 734-647-5899

University of MichiganFellowship, Infectious Disease, 1999 - 2001
University of MichiganResidency, Internal Medicine, 1993 - 1997
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1993

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

22 citations
Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline
Edward Peres, Yasser Khaled, Oleg I. Krijanovski, Shin Mineishi, John E. Levine
Transplant Infectious Disease. 2009-02-01
272 citations
Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
Emily C. Somers, Gregory A. Eschenauer, Jonathan P. Troost, Jonathan L. Golob, Tejal N Gandhi
Clinical Infectious Diseases. 2021-07-15
181 citations
Prevention and treatment of cancer-related infections, version 2.2016
Lindsey R. Baden, Sankar Swaminathan, Michael Angarone, Gayle C. Blouin, Bernard C Camins
Journal of the National Comprehensive Cancer Network. 2016-07-01

Patchwork System for Rationing a Covid Drug Sends Immunocompromised Patients on a ‘Hunger Games Hunt’January 27th, 2022
Why Do Some People Need a Third Dose of the COVID Vaccine?August 25th, 2021
As the Push to Vaccinate More Against COVID Continues, Resistance to Mandates GrowsAugust 13th, 2021
Join now to see all